Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: Retrospective study

AIDS Research and Therapy

Volumn 12, Issue 1, 2015, Pages

  Kibaru, Elizabeth Gathoni ^a,d   Nduati, Ruth ^b   Wamalwa, Dalton ^b   Kariuki, Nyambura ^b,c  

^a EGERTON UNIVERSITY   (Kenya)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d NONE   (Kenya)

Author keywords

Changes of hematological parameters; Hematological abnormalities; Paediatric HIV infection

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DAPSONE; EFAVIRENZ; HEMOGLOBIN; IRON; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ANEMIA; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE CLASSIFICATION; DRUG CHOICE; DRUG SAFETY; ERYTHROCYTE COUNT; FEMALE; HEMATOLOGIC DISEASE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; KENYA; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEDICAL RECORD REVIEW; PATIENT MONITORING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SEX RATIO; THROMBOCYTE COUNT; TREATMENT DURATION; WASTING SYNDROME;

EID: 84938934617     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/s12981-015-0069-4     Document Type: Article

References (22)

1. Spivak JL, Bender BS, Quinn TC (1984) Hematological abnormalities in the acquired immune deficiency syndrome. Am J Med 77:224
2. Ministry of Health, Government of Kenya (2005) Diagnosis and Staging of HIV in children. In: Ibrahim M, Isaiah T, Sylvia O et al. (eds) Guideline for Antiretroviral therapy in Kenya. p 56
3. Mwanda OW (1997) Hematological changes in human immunodeficiency virus infection. East Afr Med J 1:732-739
4. Moore RD (1999) Human immunodeficiency virus infection, anemia, and survival. Clin. Infect. Dis. 29:44-49 (Abstract/FREE Full Text)
5. Consolini R, Benviclli W, Legitimo A, Galli L, Tovo P et al (2007) Pre HAART follow- up study of the hematological manifestation in children with prenatal HIV infection, suggestions for reclassification of clinical disease. Italian register for HIV infection in children. Paediatri. Hematol Oncol 29:376-383
6. Adetifa IM, Temiye EO, Akinsulie AO, Ezeaka VC, Iroha EO (2006) Hematological abnormalities associated with paediatric HIV/AIDS in Lagos. Ann Trop Paediatr 26(2):121-125
7. Totin D, Ndugwa C, Mmiro F et al (2002) Iron deficiency anemia is highly prevalent among HIV infected and uninfected infants in Uganda American Society of nutritional sciences. J Nutri 132:423-429 (PubMed)
8. Eley BS, Sive AA, Shuttleworth M, Hussey GD (2002) Prospective cross sectional study of anemia and iron status in HAART naïve HIV infected children in South Africa. BMC Infect Dis 2:3 (PMC free article, PubMed)
9. Suarez DA, Rao PR, Miller JS (1994) Prevalence of lymphopenia in children with AIDS. Clin Pediatr 33(4):204-208
10. Calis JC, van Hensbroek MB, de Haan RJ, Moons P, Brabian BJ, Bates I (2008) HIV-associated anemia in children: systemic review from global perspective. AIDS 22(10):1099-1112 (PubMed)
11. Ellaurie M, Bernstein LJ, Shah K et al (1986) Thrombocytopenia in Paediatrics AIDS. Blood 68:124a
12. Karpatkin S, Nardi MA, Green D (2002) Platelet and coagulation defect associated with HIV infection. Thromb Haemost 88:389-400
13. Foote EM, Sullivan KM, Ruth LJ, Oremo J, Sadumah I, Williams TN, Suchdev PS (2013) Determinants of Anemia among Preschool Children in Rural, Western Kenya. Am J Trop Med Hyg. 88(4):757-764. doi: 10.4269/ajtmh.12-0560
14. WHO (2001) Iron Deficiency Anemia assessment, Prevention, and Control. A guide for programme Managers. http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf
15. Moyle G, Sawyer W, Law M, Amin J, Hill A (2004) Changes in hematological parameters and efficacy of thymidine analogue based highly active antiretroviral therapy: meta-analysis of six prospective, randomized comparative studies. Clin Ther 26(1):92-97
16. Mocroft A, Kirk O, Barton SE, EuroSIDA Study Group (1999) Anemia is an independent predictive marker for clinical prognosis in HIV infected patients across Europe. AIDS 13:943-950
17. Huang SS, Barbour JD, Deeks SG, Huang SJ, Grant RM et al (2000) Reversal of human immunodeficiency Virus type 1-Associated hematosuppression by effective antiretroviral therapy. Clin Infect Dis 30:504-510
18. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM et al (2007) Outcomes and CD4 cell response. Clinical in children receiving Antiretroviral Therapy at Primary health care facilities in Zambia. JAMA 289:1888-1899
19. Nacoulma EW, Some Y, Tieno H, Diallo I, Zoungrana A et al (2007) Hematological parameters evolving during antiretroviral therapy of HIV infected patients in Bukina-faso. Bull Soc Pathol 100(4):271-274
20. Kiragga AN, Castelnuovo B, Nakanjako D, Manabe YC (2010) Baseline severe anemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. J Int AIDS Soc. 13:42. doi: 10.1186/1758-2652-13-42(PMCID: PMC2991285 Published online 2010 Nov 3)
21. Esan MO, van Hensbroek MB, Nkhoma E, Musicha C, White SA, Ter Kuile FO, Phiri KS (2013) Iron supplementation in HIV-infected Malawian children with anemia: a double-blind, randomized, controlled trial. Clin Infect Dis 57(11):1626-1634. doi: 10.1093/cid/cit528(PubMed Abstract Publisher Full Text)
22. Pryce C, Pierre RB, Steel-Duncan J, Evans-Gilbert T, Palmer P, Moore J, Rodriguez B, Christie CD (2008) Safety of antiretroviral drugs in Jamaican children with HIV. West Indian Med J 57(3):238-245